Advance on the classification of prostate cancer with neuroendocrine differentiation.
10.3760/cma.j.cn112151-20230924-00210
- Author:
M ZHAO
1
;
M ZHOU
2
;
J T HUANG
3
;
Q RAO
4
;
X D TENG
5
Author Information
1. Ningbo Clinical Pathology Diagnosis Center, Ningbo 315000, China.
2. Department of Pathology, Tufts University School of Medicine, Boston 02215, U S A.
3. Department of Pathology, Duke University School of Medicine, Durham 27710, U S A.
4. Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
5. Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Publication Type:Journal Article
- MeSH:
Male;
Humans;
Prostatic Neoplasms;
Cell Line, Tumor;
Cell Differentiation;
Carcinoma, Neuroendocrine
- From:
Chinese Journal of Pathology
2023;52(12):1193-1196
- CountryChina
- Language:Chinese
